Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glycan-modified anti-CD4 antibodies for HIV prevention and therapy

Glycan-modified anti-CD4 antibodies for HIV prevention and therapy

US Patent 9790276 · Granted Oct 17, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ambient temperature barocaloric refrigerating machine based on barocaloric effec2025
Bispecific HIV-1-neutralizing antibodies2024
Engineering pH-dependent antigen binding activity into anti-HIV antibodies with 2024
Tri-specific antibodies for HIV therapy2020
Bispecific HIV-1-neutralizing antibodies2019
Bispecific HIV-1 neutralizing antibodies2018
Bispecific HIV-1 neutralizing antibodies2017
Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity2017
Glycan-modified anti-CD4 antibody with improved HIV-1 neutralizing activity2017
Fusion antibodies for HIV therapy2014
Fusion antibodies for HIV therapy2014
Glycolipids and analogues thereof as antigens for NKT cells2013